Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening

Lowering total tau levels is an attractive therapeutic strategy for Alzheimer's disease and other tauopathies. High-throughput screening in neurons derived from human induced pluripotent stem cells (iPSCs) is a powerful tool to identify tau-targeted therapeutics. However, such screens have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chao, Ward, Michael E., Chen, Robert, Liu, Kai, Tracy, Tara E., Chen, Xu, Xie, Min, Sohn, Peter Dongmin, Ludwig, Connor, Meyer-Franke, Anke, Karch, Celeste M., Ding, Sheng, Gan, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639430/
https://www.ncbi.nlm.nih.gov/pubmed/28966121
http://dx.doi.org/10.1016/j.stemcr.2017.08.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639430/
https://www.ncbi.nlm.nih.gov/pubmed/28966121
http://dx.doi.org/10.1016/j.stemcr.2017.08.019

Ejemplares similares